Assay Development

When you need to develop a biomarker for clinical trial but can’t wait the 18 to 24 months it usually requires, Veridex CRS has the answer. We’ve perfected a process that enables us to build an assay in 3 to 6 months on average, depending on the complexity. And you can be confident our assays have the robustness you need to move into clinical trials.

Our Process

We’ve built four critical milestones, or “go and no go” decision points, into our biomarker assay development process. Why? We want to make sure we’re always meeting your expectations. We also want to determine if your assay is feasible before you get too far down the road, so you don’t waste your precious resources or have to pay for a whole assay development. It’s that kind of flexibility that makes our service stand apart.

After we know your assay is feasible, we verify it to make sure it works and delivers the desired results. Next, it’s time to transfer it to our testing lab and train other scientists to use it. Finally, we validate the assay with real patient samples.

To learn more about our painstaking yet fast and efficient process, please see the graphic to the right.